White blood cells of juvenile myelomonocytic leukemia (JMML) patient with PTPN11 activating mutation exhibited significantly reduced viability in the presence of siRNAs targeting ACK1, indicating ACK1’s role in optimal SHP2 activation39. Here, TNK2 is linked to juvenile myelomonocytic leukemia.